Pasien Spinocerebellar Ataxia 3 (SCA3) dengan neuropati perifer di Indonesia : laporan kasus
Abstract
Abstract
Rationale: Spinocerebellar ataxia (SCA) 3, also known as Machado-Joseph Disease (MJD), is a neurodegenerative disease which involves cerebellum and its afferent and efferent pathways. Generally, the initial symptoms were gait disturbance, double vision, dysarthria, and vertigo.
Patient concerns:
a 43-year-old male, with known SCA3, presented hereditary ataxia had mild numbness in his both palms since two years ago. Sensory examination found no abnormality. Nerve Conduction Studies (NCS) showed severe axonal demyelinating sensorimotor peripheral neuropathy. In magnetic resonance imaging atrophy cerebellum with cerebral multiple lacunar infarction were seen.
Diagnoses: SCA3 was diagnosed on the basis of clinical features, family pedigree, physical examination, electrophysiology study, neuroimaging, nerve biopsy, and genetic testing results. The electrophysiological manifestations revealed profound axonal demyelinating lesion in peripheral nerves. Genetic analysis was not done yet due to lack of availability of genetic testing in our country at this moment although it is the gold standard for diagnosis.
Lessons: SCA3 with peripheral neuropathy represents a specific clinical entity that so far has never been described previously in Indonesia.
Abbreviations: SCA3 = Spinocerebellar ataxia, MJD = Machado-Joseph Disease, NCS = Nerve Conduction Studies
Keywords
References
Shakkottai VG, Fogel BL. Clinical Neurogenetics : Autosomal Dominant Spinocerebellar Ataxia. Neurol Clin. 2013;31(4).
Jayadev S, Bird TD. Hereditary Ataxias : Overview. Volume 15 | Number 9 | September 2013 | Genetics in Medicine. 2013;15(9):673-83.
Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, DiDonato S, et al. Early Symptoms in Spinocerebellar Ataxia Type 1, 2, 3, and 6. Movement Disorders. 2008;23(25):2232–8.
van de Warrenburg BP, Notermans NC, Schelhaas HJ, van Alfen N, Sinke RJ, Knoers NV, et al. Peripheral Nerve Involvement in Spinocerebellar Ataxias. Arch Neuronal. 2004;61(11):1757–60.
Mallik A, Weir AI. Nerve Conduction Study : Essentials and Pitfalls in Practice. J Neurol Neurosurg Psychiatry. 2005;76(II):ii23–ii31.
Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy. Diabetes Care. 2002;25(11):2048-52.
Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the Assessment and Rating of Ataxia: Development of a New Clinical Scale. Neurology. 2006;66(11):1717-20.
Velázquez-Perez L, Rodríguez-Labrada R, Canales-Ochoa N, Sanchez-Cruz G, Fernandez-Ruiz J, Montero JM, et al. Progression Markers of Spinocerebellar Ataxia 2. A Twenty Years Neuphysiological Follow Up Study. Journal of The Neurological Science. 2009;290(1-2):22-6.
Velázquez Pérez L. Sánchez Cruz G, Canales Ochoa N, Rodríguez Labrada R, Rodríguez Díaz J, Almaguer Mederos L, et al. Electrophysiological Features in Patients and Presymptomatic Relatives with Spinocerebellar Ataxia Type 2. J Neurol Sci. 2007;263(1-2):158–64.
Schöls L, Linnemann C, Globas C. Electrophysiology in Spinocerebellar Ataxias: Spread of Disease and Characteristic Findings. The Cerebellum. 2008;7(2):198-203.
Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hübsch T, Szymanski S, Berciano J, van de Warrenburg BP, et al. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6. Cerebellum. 2015;15(2):165–73.
Coutinho P, Guimarães A, Pires MM, Scaravilli F. The Peripheral Neuropathy in Machado-Joseph Disease Acta Neuropathol. 1986;71(1-2):119-24.
Yadav R, Pal PK, Krishna N, Amar BR, Jain S, Purushottam M. Electrophysiological Evaluation of Spinocerebellar Ataxias 1, 2 and 3. Journal of the Neurological Sciences 2011;312(1-2):142-5.
Lin KP, Soong BW. Peripheral Neuropathy of Machado Joseph Disease in Taiwan: a Morphometric and Genetic Study. Eur Neurol. 2002;48(4):210-7.
McLeod JG, Evans WA. Peripheral Neuropathy in Spinocerebellar Degenerations. Muscle & Nerve. 1981;4(1):51-61.
England JD, Asbury AK. Peripheral Neuropathy. Lancet Neurol 2004;363(9427):2151–61.
Shapiro BE et al. Polyneuropathy. In: Shapiro BE PD, editor. Electromyohraphy and Neuromuscular Disorders, Clinical-Electrophysiologic Correlations. 3rd ed. USA: Elsevier; 2013. p. 37-43.
JM Vallat. Dominantly Inherited Peripheral Neuropathies. Journal of Neuropathology & Experimental Neurology. 2003;62(7):699-714.
Kuhlenbaumer G et al. Hereditary Peripheral Neuropathies: Springer; 2005.
Abele M, Bürk K, Andres F, Topka H, Laccone F, Bösch S, et al. Autosomal Dominant Cerebellar Ataxia Type I: Nerve Conduction and Evoked Potential Studies in Families with SCA1, SCA2, and SCA3. Brain. 1997;120(Pt 12):2141-8.
Moro A, Munhoz RP, Arruda WO, Raskin S, Moscovich M, Teive HA. Spinocerebellar Ataxia Type 3: Subphenotypes in A Cohort of Brazilian Patients. Arquivos de Neuro-Psiquiatria. 2014;72(9):659-62.
Stevanin G, Bouslam N, Thobois S, Azzedine H, Ravaux L, Boland A, et al. Spinocerebellar Ataxia with Sensory Neuropathy (SCA25) Maps to Chromosome 2p. Ann Neurol. 2004;55(1):97-104.
Klockgether T, Schöls L, Abele M, Bürk K, Topka H, Andres F, et al. Age Related Axonal Neuropathy in Spinocerebellar Ataxia Type 3 / Machado-Joseph Disease (SCA3/MJD). J Neurol Neurosurg Psychiatry. 1999;66(2):222-4.
DOI: 10.24815/jks.v21i2.20529
Refbacks
- There are currently no refbacks.